Consistently, immunoblotting analysis of the tumor extracts showed that the β-catenin protein level in the xStAx-VHLL group was apparently decreased compared with other groups, indicating that xStAx-VHLL achieved effective and durable degradation of β-catenin (Fig. 3d). This evidence concerns the gene VHLL and neoplasm.